The Smoking Consequences Questionnaire: Factor structure and predictive validity among Spanish-speaking Latino smokers in the United States.
BACKGROUND
Much of the existing research on smoking outcome expectancies has been guided by the Smoking Consequences Questionnaire (SCQ ). Although the original version of the SCQ has been modified over time for use in different populations, none of the existing versions have been evaluated for use among Spanish-speaking Latino smokers in the United States.


METHODS
The present study evaluated the factor structure and predictive validity of the 3 previously validated versions of the SCQ--the original, the SCQ-Adult, and the SCQ-Spanish, which was developed with Spanish-speaking smokers in Spain--among Spanish-speaking Latino smokers in Texas.


RESULTS
The SCQ-Spanish represented the least complex solution. Each of the SCQ-Spanish scales had good internal consistency, and the predictive validity of the SCQ-Spanish was partially supported. Nearly all the SCQ-Spanish scales predicted withdrawal severity even after controlling for demographics and dependence. Boredom Reduction predicted smoking relapse across the 5- and 12-week follow-up assessments in a multivariate model that also controlled for demographics and dependence.


CONCLUSIONS
Our results support use of the SCQ-Spanish with Spanish-speaking Latino smokers in the United States.
Vidrine
Jennifer Irvin
JI
Department of Health Disparities Research, Unit 1440, The University of Texas M. D. Anderson Cancer Center, PO BOX 301402, Houston, TX 77230-1402, USA. jirvinvidrine@mdanderson.org
Vidrine
Damon J
DJ
Costello
Tracy J
TJ
Mazas
Carlos
C
Cofta-Woerpel
Ludmila
L
Mejia
Luz Maria
LM
Wetter
David W
DW
D000328:Adult; D005260:Female; D006630:Hispanic or Latino; D006801:Humans; D008297:Male; D012907:Smoking / Q000009:adverse effects*; D016540:Smoking Cessation; D013375:Substance Withdrawal Syndrome; D011795:Surveys and Questionnaires; D014481:United States
Br J Addict. 1991 May;86(5):593-7
1859925
Exp Clin Psychopharmacol. 2000 Feb;8(1):88-96
10743908
MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1221-6
19008790
Exp Clin Psychopharmacol. 1999 May;7(2):135-44
10340153
Am J Public Health. 2001 Sep;91(9):1424-30
11527775
Psychopharmacology (Berl). 2006 Aug;187(3):385-96
16752139
Psychol Addict Behav. 2000 Sep;14(3):219-30
10998948
Exp Clin Psychopharmacol. 1999 Nov;7(4):354-61
10609970
J Consult Clin Psychol. 2002 Feb;70(1):216-27
11860048
Nicotine Tob Res. 2007 Nov;9 Suppl 4:S555-70
18067032
MMWR Morb Mortal Wkly Rep. 2004 Oct 15;53(40):935-7
15483525
J Abnorm Psychol. 2000 Feb;109(1):74-86
10740938
Drug Alcohol Depend. 2005 Mar 7;77(3):259-68
15734226
Ann Behav Med. 2005 Feb;29(1):22-8
15677297
J Consult Clin Psychol. 1996 Apr;64(2):366-79
8871421
Am J Prev Med. 1996 Sep-Oct;12(5):378-87
8909649
J Abnorm Psychol. 1994 Nov;103(4):801-11
7822583
Value Health. 2004 Sep-Oct;7 Suppl 1:S27-30
15367241
Psychol Bull. 1992 Jan;111(1):23-41
1539088
Am Psychol. 2004 May-Jun;59(4):224-35
15149263
Psychol Assess. 2003 Jun;15(2):163-72
12847776
Nicotine Tob Res. 2005 Feb;7(1):81-90
15804680
Health Psychol. 1991;10(1):42-5
2026129
Addiction. 2007 Oct;102 Suppl 2:5-29
17850611
Br J Addict. 1991 Sep;86(9):1119-27
1932883
Psychol Rev. 2004 Jan;111(1):33-51
14756584
Addict Behav. 2007 Jul;32(7):1405-15
17137728
J Pers Soc Psychol. 1997 Jan;72(1):184-95
9008380
MMWR Morb Mortal Wkly Rep. 2007 Nov 9;56(44):1157-61
17989644
Br J Addict. 1989 Jul;84(7):791-9
2758152
Nicotine Tob Res. 1999 Sep;1(3):251-7
11072422
Cancer. 2007 Jan 15;109(2 Suppl):406-13
17149758
Addiction. 2007 Oct;102 Suppl 2:104-11
17850620
Nebr Symp Motiv. 1986;34:257-323
3627296
Nicotine Tob Res. 2003 Feb;5(1):13-25
12745503
JAMA. 1990 Sep 26;264(12):1546-9
2395194
J Abnorm Psychol. 2005 Nov;114(4):661-75
16351387